Table 3.
Disease | CDH17 | HER2 |
---|---|---|
Primary | ||
Grade 2 | 63.6% (7/11) | 27.3% (3/11) |
Grade 3 | 56.5% (13/23) | 8.70% (2/23) |
LN | ||
Grade 2 | 85.7% (6/7) | 28.6% (2/7) |
Grade 3 | 51.9% (14/27) | 7.41% (2/27) |
Primary primary gastric cancer, LN lymph node metastasis
Disease | CDH17 | HER2 |
---|---|---|
Primary | ||
Grade 2 | 63.6% (7/11) | 27.3% (3/11) |
Grade 3 | 56.5% (13/23) | 8.70% (2/23) |
LN | ||
Grade 2 | 85.7% (6/7) | 28.6% (2/7) |
Grade 3 | 51.9% (14/27) | 7.41% (2/27) |
Primary primary gastric cancer, LN lymph node metastasis